DK0381218T3 - Gemfibrozil-præparat med forhalet frigivelse - Google Patents

Gemfibrozil-præparat med forhalet frigivelse

Info

Publication number
DK0381218T3
DK0381218T3 DK90102021.4T DK90102021T DK0381218T3 DK 0381218 T3 DK0381218 T3 DK 0381218T3 DK 90102021 T DK90102021 T DK 90102021T DK 0381218 T3 DK0381218 T3 DK 0381218T3
Authority
DK
Denmark
Prior art keywords
gemfibrozil
preparation
delayed release
granulation
disintegratable
Prior art date
Application number
DK90102021.4T
Other languages
Danish (da)
English (en)
Inventor
Isaac Ghebre-Sellassie
Mahdi Fawzi
Uma Iyer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0381218T3 publication Critical patent/DK0381218T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90102021.4T 1989-02-02 1990-02-01 Gemfibrozil-præparat med forhalet frigivelse DK0381218T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/305,083 US4925676A (en) 1989-02-02 1989-02-02 Extended release gemfibrozil composition

Publications (1)

Publication Number Publication Date
DK0381218T3 true DK0381218T3 (da) 1993-06-01

Family

ID=23179257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90102021.4T DK0381218T3 (da) 1989-02-02 1990-02-01 Gemfibrozil-præparat med forhalet frigivelse

Country Status (20)

Country Link
US (1) US4925676A (de)
EP (1) EP0381218B1 (de)
JP (1) JPH02235810A (de)
CN (1) CN1044590A (de)
AT (1) ATE88888T1 (de)
AU (1) AU624217B2 (de)
CA (1) CA2009134A1 (de)
DE (1) DE69001487T2 (de)
DK (1) DK0381218T3 (de)
ES (1) ES2055176T3 (de)
FI (1) FI900492A0 (de)
HU (1) HU204194B (de)
IE (1) IE900372L (de)
IL (1) IL92995A0 (de)
MY (1) MY104899A (de)
NO (1) NO900483L (de)
NZ (1) NZ232322A (de)
PH (1) PH26308A (de)
PT (1) PT93028A (de)
ZA (1) ZA90778B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
EP0462067A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil-Formulierung
EP0462066A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphes Gemfibrozil
EP0475894A1 (de) * 1990-08-27 1992-03-18 Warner-Lambert Company Verbesserte Gemfibrozil-Formulierungen
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
EP0522128B1 (de) * 1991-01-30 1996-01-17 The Wellcome Foundation Limited Wasserlösliche tabletten
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
JPH07503236A (ja) * 1991-11-26 1995-04-06 ワーナー−ランバート・コンパニー 制御放出性ジェムフィブロジル剤形の開発のための方法および組成物
US5358723A (en) * 1991-11-26 1994-10-25 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
DE60313359T2 (de) * 2002-12-17 2008-01-03 Abbott Gmbh & Co. Kg Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
EP1753398B1 (de) * 2004-06-10 2018-09-19 Glatt Air Techniques, Inc. Pharmazeutische darreichungsformulierung mit kontrollierter freisetzungsmatrix

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
EP0212747B1 (de) * 1985-08-16 1991-04-10 The Procter & Gamble Company Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller Freisetzung
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
EP0276807A3 (de) * 1987-01-27 1988-10-12 Warner-Lambert Company Lipide regulierende Zusammensetzungen

Also Published As

Publication number Publication date
ZA90778B (en) 1991-10-30
NO900483D0 (no) 1990-02-01
CN1044590A (zh) 1990-08-15
ES2055176T3 (es) 1994-08-16
NZ232322A (en) 1991-02-26
ATE88888T1 (de) 1993-05-15
DE69001487D1 (de) 1993-06-09
MY104899A (en) 1994-06-30
EP0381218A3 (en) 1990-12-05
HUT52952A (en) 1990-09-28
HU204194B (en) 1991-12-30
EP0381218B1 (de) 1993-05-05
US4925676A (en) 1990-05-15
IL92995A0 (en) 1990-09-17
CA2009134A1 (en) 1990-08-02
JPH02235810A (ja) 1990-09-18
NO900483L (no) 1990-08-03
AU624217B2 (en) 1992-06-04
FI900492A0 (fi) 1990-01-31
PH26308A (en) 1992-04-29
IE900372L (en) 1990-08-02
AU4899090A (en) 1990-08-09
EP0381218A2 (de) 1990-08-08
HU900640D0 (en) 1990-04-28
PT93028A (pt) 1990-08-31
DE69001487T2 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
DK0381218T3 (da) Gemfibrozil-præparat med forhalet frigivelse
FR2665360B1 (fr) Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
NO900338D0 (no) Fremgangsmaate for befestigelse av en slange til en nippelog en derved tilveiebragt forbindelse.
NO892826D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
BR8901139A (pt) Parafuso de retencao com esfera de engate
DK362888D0 (da) Fremgangsmaade til fremstilling af en ukomprimeret tablet med en massefylde under en
NO904513D0 (no) Fremgangsmaate for fremstilling av et naeringsmiddel.
NO844842L (no) Fremgangsmaate for fremstilling av akryl kopolymerharpiks med hoeyt faststoff-innhold
AU1937788A (en) 4h-3,1-benzoxazin-4-one compounds and serine protease- inhibiting medicinal composition containing same
IL59764A (en) Programmed release pharmaceutical composition based on dihydroergotoxine and procedure for its manufacture
FR2621368B1 (fr) Joint homocinetique du type tripode a retenue axiale
DK309789D0 (da) Fremgangsmaade til fremstilling af alumoxaner
NO921603D0 (no) Fremgangsmaate til fremstilling av et aktivt findelt agregat for bruk til betong
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
USD282085S (en) Hexagonal board for a game
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
USD308551S (en) Game board
GB2201591B (en) Analgesic antipyretic and anti-inflammatory compositions.
IT212057Z2 (it) Cacciavite prensile con aggancio e sgancio automatico della vite.
ES542334A0 (es) "procedimiento de preparacion de monomeros de estireno de anillo halogenado"
DK162506C (da) Fremgangsmaade til fremstilling af et tabletterbart granulat
IT211002Z2 (it) Presa-jack corredata di dado di serraggio incorporante un dispositivo di aggancio e disinnesto rapido della spina-jack
AU2446988A (en) Device for the combustion of unburned substances
ES531229A0 (es) Un procedimiento de preparacion de esteres tiofosforicos y tiofosfonicos heterociclicos
NO890539L (no) Fremgangsmaate for fremstilling av lipofile oxadiazoler.